Platform would give patients greater access to experimental drugs

02/20/2014 | TechCrunch

A Dutch startup called myTommorows has raised a total of $6 million to develop a platform connecting patients, doctors and drugmakers to give patients with life-threatening diseases access to drugs still in the development stage. "We allow doctors and biotech companies to help patients with unmet medical needs, given the complicated nature of providing access to development-stage drugs," myTomorrows chief financial officer Erdem Yavuz said.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Regulatory Compliance Specialist
Brooklyn, NY
Director of Utilization Management
Meridian Health Plan
Chicago, IL
Senior Manager, Healthcare Reform
Avalere Health
Washington, DC
Regulatory Senior Managing/Principal Engineer/Scientist
Menlo Park, CA
Director of Claims
Meridian Health Plan
Detroit, MI